AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Evaluation of Maxillary Expansion Methods on Nasomaxillary Structures

RecruitingNAAges 15 Years - anyAllMerve Kulaksız
💬

In plain words

What the trial is, and whether it could suit you

Maxillary transverse deficiency is an orthodontic anomaly characterized by the upper and lower dental arches being incompatible due to insufficient width of the maxilla. This condition typically manifests with clinical symptoms such as crossbite, crowding of teeth, and impaired respiratory function. Genetic factors, early primary tooth loss, mouth breathing, thumb sucking, and abnormal swallowing are among the causes of maxillary narrowing. Treatment options vary depending on the patient's age and the degree of suture closure. In pediatric and adolescent patients, rapid (RPE) or slow (SPE) orthodontic expansion can be achieved with palatal expansion appliances. However, in adult patients, due to the less flexible bone structure of the maxilla, methods such as surgically assisted expansion (SARME) or mini-screw-assisted expansion (MARPE) are preferred. Recent studies have shown that MARPE

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of maxillary transverse deficiency. * Patients aged 15 years and older. * Presence of unilateral or bilateral crossbite. Exclusion Criteria: * Severe facial deformities or craniofacial syndromes. * History of previous orthodontic treatment. * Existing pathology or history of surgery related to the paranasal sinuses, nasolacrimal system, or orbital cavity. * Inadequate patient cooperation. * History of trauma, or previous maxillofacial/plastic surgery procedures. * Clinical signs or symptoms of maxillary sinus pathology (e.g., maxillary sinus cysts, sinusitis).
💊

What it tests

  • MARPE (Mini-Screw Assisted Rapid Palatal Expansion)
  • SARME (Surgically Assisted Rapid Maxillary Expansion)
📍

Where

1 site
Bezmialem Vakif University Faculty of Dentistry, Department of Orthodontics
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy